List of works by Yuliya Lokhnygina

1823. Signal or Noise? A Comparison of Methods to Identify Outliers in Antimicrobial Use (AU)

2159. Methodological Threats to the Standardized Infection and Standardized Antimicrobial Administration Ratios

854. The Impact of the CMS SEP-1 Core Measure on Antimicrobial Utilization: a Multicenter Interrupted Time-Series (ITS) Analysis

article by Deverick J. Anderson et al published November 2018 in Open Forum Infectious Diseases

855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

scientific article

Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation

scientific article published on 24 September 2013

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

scientific article published on 27 April 2016

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

scientific article

Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality

scientific article

An evaluation of constrained randomization for the design and analysis of group-randomized trials

scientific article published on 23 November 2015

An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design

scientific article published on 15 March 2010

Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

scientific article published on 10 July 2014

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial

scientific article published on May 2016

Automatic cone photoreceptor segmentation using graph theory and dynamic programming

scientific article published on 22 May 2013

Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.

scientific article published on 15 May 2017

Body image and body satisfaction differ by race in overweight postpartum mothers

scientific article

Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial

scientific article published on 22 August 2012

Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition

scientific article published on 4 October 2017

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

scientific article published on 5 December 2017

Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.

scientific article

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

scientific article

Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow.

scientific article published on 21 May 2015

Comparison of concordance correlation coefficient and coefficient of individual agreement in assessing agreement

scientific article published in January 2007

Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease

scientific article

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes

scientific article published on 18 September 2017

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition

scientific article published on 11 June 2015

Cox regression methods for two-stage randomization designs.

scientific article published on 9 April 2007

Denominator Matters in Estimating Antimicrobial Use: A Comparison of Days Present and Patient Days.

scientific article published on 26 March 2018

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr

scientific article

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 14 September 2017

Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.

scientific article

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

scientific article

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin,

scientific article published in December 2006

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Em

scientific article

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

scientific article published on 13 April 2017

Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study

scientific article published on 16 January 2017

Evaluation of Selvester QRS score for use in presence of conduction abnormalities in a broad population

scientific article published on 9 May 2015

Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.

scientific article published on 04 January 2017

Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions

scientific article published on 10 November 2015

Gender differences in the rates and correlates of HIV risk behaviors among drug abusers

scientific article

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

scientific article published on 18 February 2015

Harvesting the Low Hanging Fruit: A Benchmarking Tool for Implementation of Intravenous to Oral Antibiotic Switch Programs in 14 Southeastern Community Hospitals

scientific article published on 9 December 2015

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

scientific article

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin

scientific article published on 28 August 2017

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

scientific article

Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures

scientific article published on 9 February 2016

Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices

scientific article published on 14 January 2018

Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies

scientific article published on April 2010

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

article

Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis

scientific article published on 09 October 2009

Longitudinal reproducibility of optical coherence tomography measurements in children

scientific article

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization

scientific article published on June 2015

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

scientific article

Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy

scientific article published on 2 May 2013

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

scientific article published on 17 February 2016

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

scientific article published on July 2016

On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).

scientific article published on 23 September 2016

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial

scientific article published on 14 March 2013

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

scientific article published on February 2013

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

scientific article

Pancreatic Safety of Sitagliptin in the TECOS Study

scientific article published on 14 September 2016

Platelet Factor 4/Heparin Antibodies in Blood Bank Donors ⬇️

scientific article published on November 1, 2010

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

scientific article published on 25 August 2012

Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction

scientific article published on March 2012

Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.

scientific article published on 19 September 2006

Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial

scientific article

Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers

scientific article published on March 2013

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis

scientific article

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

scientific article published on February 2016

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

scientific article

Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial

scientific article published on 28 February 2012

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

scientific article

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

scientific article

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

scientific article published on 03 December 2012

Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Fac

article by Jonathan P Piccini et al published 10 September 2013 in Circulation

Risk indexes for exacerbations and hospitalizations due to COPD

scientific article published on 01 January 2007

Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment El

scientific article published on 25 July 2013

Safety of a peanut oral immunotherapy protocol in children with peanut allergy

scientific article published on 27 May 2009

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

scientific article published on 16 June 2017

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY

article by Chee Tang Chin et al published July 2010 in American Heart Journal

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

scientific article published on April 2016

Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes

scientific article published on 29 May 2012

The Antimicrobial Scrub Contamination and Transmission (ASCOT) Trial: A Three-Arm, Blinded, Randomized Controlled Trial With Crossover Design to Determine the Efficacy of Antimicrobial-Impregnated Scrubs in Preventing Healthcare Provider Contaminati

scientific article

The impact of postrandomization crossover of therapy in acute coronary syndromes care

scientific article published on 08 February 2011

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

scientific article

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

scientific article published on 19 November 2007

Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials

scientific article (publication date: October 2007)

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

scientific article published in March 2017

Transfusion-related biologic effects and free hemoglobin, heme, and iron

scientific article published on 6 August 2012

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

scientific article

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

scientific article published on 17 February 2012

Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation

scientific article published on 30 June 2014

Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation

scientific article published on January 2014

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

scientific article

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

scientific article published on 22 June 2016

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

scientific article

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

scientific article published on 18 June 2014

Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).

scientific article

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

scientific article published on 16 September 2014

Paulina is supported by:

About Paulina

Help